Akira Yano

Dr. Akira Yano


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
NNNozomi Nagahora
Nozomi Nagahora
HYHidetoshi Yamada
Hidetoshi Yamada
SKSayaka Kikuchi
Sayaka Kikuchi
MHMayuka Hakozaki
Mayuka Hakozaki
AYAkira Yano
Akira Yano
5-hydroxyeicosatetraenoic acid (5-HETE) and 5-hydroxyeicosapentaenoic acid (5-HEPE) are major metabolites produced by 5-lipoxygenase (5-LOX) from arachidonic acid (AA) and eicosapentaenoic acid (EPA). Effects of hydroxides on endothelial cells are unclear, although 5-LOX is known to increase at arteriosclerotic lesions. To investigate the effects of hydroxides on human umbilical vein endothelial cells (HUVECs), the cells were treated with 50 μM each of AA, EPA, 5-HETE, and 5-HEPE. Treatment of HUVECs with 5-HETE and 5-HEPE, rather than with AA and EPA, increased the nuclear translocation of NF-E2 related factor 2 (Nrf2) and upregulated the expression of heme oxygenase-1 and cystine/glutamate transporter regulated by Nrf2. Reactive oxygen species (ROS) generation was markedly elevated in HUVECs after treatment with 5-HETE and 5-HEPE, and the pretreatment with α-tocopherol abrogated ROS levels similar to those in the vehicle control. However, ROS generation was independent of Nrf2 activation induced by 5-HETE and 5-HEPE. 5-HETE was converted to 5-oxo-eicosatetraenoic acid (5-oxo-ETE) in HUVECs, and 5-oxo-ETE increased Nrf2 activation. These results suggest that 5-HETE works as an Nrf2 activator through the metabolite 5-oxo-ETE in HUVECs. Similarly, 5-HEPE works in the same way, because 5-HEPE is metabolized to 5-oxo-eicosapentaenoic acid through the same pathway as that for 5-HETE.

1 November 2009 in Microbiological Research
Verified
Journal Article
Closed access
AYAkira Yano
Akira Yano
SKSayaka Kikuchi
Sayaka Kikuchi
YNYuko Nakagawa
Yuko Nakagawa
YSYuichi Sakamoto
Yuichi Sakamoto
TSToshitsugu Sato
Toshitsugu Sato

1 June 2012 in Archives of Oral Biology
Verified
Journal Article
Closed access
AYAkira Yano
Akira Yano
SKSayaka Kikuchi
Sayaka Kikuchi
TTTohru Takahashi
Tohru Takahashi
KKKeiko Kohama
Keiko Kohama
YYYasuo Yoshida
Yasuo Yoshida

10 November 2009 in Applied Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
AYAkira Yano
Akira Yano
SKSayaka Kikuchi
Sayaka Kikuchi
YYYoshihisa Yamashita
Yoshihisa Yamashita
YSYuichi Sakamoto
Yuichi Sakamoto
YNYuko Nakagawa
Yuko Nakagawa
YYYasuo Yoshida
Yasuo Yoshida

1 March 2013 in Vaccine
Verified
Journal Article
Closed access
AYAkira Yano
Akira Yano
YMYoshikatsu Miwa
Yoshikatsu Miwa
YKYoshito Kanazawa
Yoshito Kanazawa
KIKaori Ito
Kaori Ito
MMMitsuhiro Makino
Mitsuhiro Makino
TNTosiki Nisizawa
Tosiki Nisizawa

11 December 2013 in Marine Drugs
Verified
Journal Article
Open access
PDF file
AYAkira Yano
Akira Yano
AAAkiko Abe
Akiko Abe
FAFumie Aizawa
Fumie Aizawa
HYHidetoshi Yamada
Hidetoshi Yamada
KMKentaro Minami
Kentaro Minami
MKMitsuo Kishi
Mitsuo Kishi
We conducted a double-blind randomized controlled study of elderly individuals in a nursing home to investigate the effect of the consumption of jelly containing sea cucumber on their oral Candida load. The jelly contained a hydrolysate of the sea cucumber Stichopus japonicus, which contained triterpene glycosides called holotoxins. The holotoxins worked as a fungicide, and their minimum inhibitory concentrations for Candida albicans were 7 µg/mL. Eight individuals in the nursing home took the sea cucumber jelly for a week and their oral Candida were counted before and after the intervention. Nine individuals took a control jelly without S. japonicus. The sea cucumber jelly showed inhibitory effects on the oral Candida. Thus, daily consumption of the S. japonicus jelly has the potential to reduce the oral Candida load in the elderly in nursing homes.